Hale Family Center For Pancreatic Cancer Research
 
Skip to content
  • Home
  • About
  • Research
    • Early Detection
    • Novel Target Discovery
    • Novel Drug Development
    • Preclinical Cancer Model Systems
    • Cancer Immunotherapy
    • Personalized Treatment
  • Investigators & Staff
    • Brian M. Wolpin, MD, MPH
    • Andrew Aguirre, MD, PhD
    • James Cleary, MD, PhD
    • Stephanie K. Dougan, PhD
    • Nathanael Gray, PhD
    • William C. Hahn, MD, PhD
    • Joseph D. Mancias, MD, PhD
    • Franziska Michor, PhD
    • Sahar Nissim, MD, PhD
    • Jonathan Nowak, MD, PhD
    • Kimberly Perez, MD
    • Michael Rosenthal, MD, PhD
    • Srivatsan Raghavan, MD, PhD
    • William Freed-Pastor, MD, PhD
    • Kevin M. Haigis, PhD
    • Brandon Huffman, MD
    • Jinhua Wang, PhD
    • Neetu Saxena, PhD, CRP
    • Sloane Furniss, PhD
    • Matthew B. Yurgelun, MD, CGAF, FASCO
    • Matthew Vander Heiden, MD, PhD
    • Eliezer M. Van Allen, MD
  • Strategic Alliances
  • Join The Hale Center
  • For Patients
  • News
  • Donate
  • Contact Us

News

Drs. Hahn, Aguirre, and Dougan receive news that their grant application on pancreatic ductal adenocarcinoma and the tumor microenvironment has been funded by the NIH

June 29, 2017

Drs. Hahn, Aguirre, and Dougan receive news that their grant application on pancreatic ductal adenocarcinoma and the tumor microenvironment has been funded by the NIH (U01 CA224146-01).

Continue reading

Dr. Wolpin published a study in J Clin Oncol demonstrating that cigarette smoking is associated with reduced survival from pancreatic cancer

June 1, 2017

Dr. Wolpin published a study in J Clin Oncol demonstrating that cigarette smoking is associated with reduced survival from pancreatic cancer(Yuan C, et al., Cigarette Smoking and Pancreatic Cancer Survival. J Clin Oncol. 2017;35(16):1822-8.).

Continue reading

Dr. Wolpin is appointed as the new Director of the Gastrointestinal Cancer Center

May 15, 2017

Dr. Wolpin is appointed as the new Director of the Gastrointestinal Cancer Center.

Continue reading

Dr. Wolpin is appointed as the Robert T. and Judith B. Hale Chair in Pancreatic Cancer

February 21, 2017

Dr. Wolpin is appointed as the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute.

Continue reading

Drs. Hahn and Aguirre published in Cell Rep that the ATXN1L-CIC-ETS transcription factor axis modulates sensitivity to MAPK pathway inhibition

February 7, 2017

Drs. Hahn and Aguirre published in Cell Rep that the ATXN1L-CIC-ETS transcription factor axis modulates sensitivity to MAPK pathway inhibition (Wang B, et al., ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition. Cell Rep. 2017;18(6):1543-57.).

Continue reading

1234
  • WE

    ARE

    HIRING!

  • 450 Brookline Avenue, Boston, MA 02215
    Patients can make an appointment here or call 877-442-3324.
  • Sitemap
  • Contact
  • Admin

Copyright 2018 | Privacy Policy | Legal Statements

Site Developed By Health Communication Core